114 related articles for article (PubMed ID: 2746045)
1. Tumor markers, liver function tests and symptoms in 115 patients with isolated colorectal liver metastases.
Lorenz M; Baum RP; Oremek G; Inglis R; Reimann-Kirkowa M; Hör G; Seiffert U; Hottenrott C
Int J Biol Markers; 1989; 4(1):18-26. PubMed ID: 2746045
[TBL] [Abstract][Full Text] [Related]
2. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
[TBL] [Abstract][Full Text] [Related]
4. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
5. Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?
Stojkovic Lalosevic M; Stankovic S; Stojkovic M; Markovic V; Dimitrijevic I; Lalosevic J; Petrovic J; Brankovic M; Pavlovic Markovic A; Krivokapic Z
Hell J Nucl Med; 2017; 20(1):41-45. PubMed ID: 28315907
[TBL] [Abstract][Full Text] [Related]
6. CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen.
Mavligit GM; Estrov Z
Am J Clin Oncol; 2000 Apr; 23(2):213-5. PubMed ID: 10776987
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
Kim SB; Fernandes LC; Saad SS; Matos D
Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
[TBL] [Abstract][Full Text] [Related]
8. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma.
Rocklin MS; Senagore AJ; Talbott TM
Dis Colon Rectum; 1991 Sep; 34(9):794-7. PubMed ID: 1914746
[TBL] [Abstract][Full Text] [Related]
9. [Arginase as a marker of cancerogenesis. III. Comparison of arginase activity with CEA and Ca 19-9 in liver metastases of colorectal cancer].
Porembska Z; Skwarek A; Chrzanowska A; Mielczarek M; Nyckowski P; Barańczyk-Kuźma A
Pol Merkur Lekarski; 2004 Jan; 16(91):31-3. PubMed ID: 15074017
[TBL] [Abstract][Full Text] [Related]
10. CA 19-9 as a marker in addition to CEA to monitor colorectal cancer.
Stiksma J; Grootendorst DC; van der Linden PW
Clin Colorectal Cancer; 2014 Dec; 13(4):239-44. PubMed ID: 25442815
[TBL] [Abstract][Full Text] [Related]
11. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
12. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
Pakdel A; Malekzadeh M; Naghibalhossaini F
Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.
Goldstein MJ; Mitchell EP
Cancer Invest; 2005; 23(4):338-51. PubMed ID: 16100946
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
von Kleist S
Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
Zhang D; Yu M; Xu T; Xiong B
Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
[TBL] [Abstract][Full Text] [Related]
18. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
[TBL] [Abstract][Full Text] [Related]
20. Serial levels of CA 19-9 and CEA in colonic cancer.
Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
